March 26-28, 2019

Boston, USA

About Event

Why Attend The 2nd Antigen-Specific Immune Tolerance Drug Development Summit 2019?

Join your peers at the 2nd Antigen-Specific Immune Tolerance Drug Development Summit 2019 and become central to leading industry conversations dedicated to overcoming the challenge of discovering and defining monogenic and multigenic antigens present in very complex diseases that do not replicate well in animal models and improving tolerance delivery systems in order to robustly translate and generate human clinical data to develop effective therapies for the unmet fields of allergy and autoimmunity.

Top Reasons to Attend:

View the full event guide to find out more.